Fig. 7: Study of TaRiboTACs-mediated radiotherapy of lung tumors.

a Monitoring of the subcutaneous A549-Luc tumor growth in different groups of mice receiving various treatments. b Tumor growth profiles of the mice in each treatment group. c Tumor volumes of the mice in each treatment group. d Tumor photograph of each group at the end of treatment. e Survival rate of the mice for each treatment group. f H&E, tunnel, and ki67 staining images of tumor slices 2 days after indicated treatments (yellow arrows mark areas of necrosis). Data denote the mean ± standard deviation. Two-sided unpaired t-test. Source data are provided as a Source Data file.